Company Filing History:
1 out of 13 
1 out of 59 
1 out of 6 Years Active: 2006-2025
Title: Innovations and Contributions of Inventor Francois Collin
Introduction
Francois Collin is a notable inventor based in Berkeley, California, recognized for his significant contributions to the field of cancer research. With a total of three patents to his name, Collin has developed innovative methods that enhance the understanding and assessment of diseases, particularly cancer.
Latest Patents
Collin's latest patents include groundbreaking methods such as "Multi-omic assessment using proteins and nucleic acids." This patent describes multi-omic methods for assessing diseases like cancer by integrating various types of data, including proteomic, transcriptomic, genomic, lipidomic, and metabolomic information. The methods also focus on screening for diseases or disease states from biological samples, particularly in determining whether a nodule, mass, or cyst is cancerous.
Another significant patent is "Methods of predicting cancer risk using gene expression in premalignant tissue." This disclosure provides methods for assessing a patient's cancer risk and recurrence risk by analyzing gene expression levels in biological samples obtained from the gastrointestinal tract. It includes the assessment of the V600E mutation of the BRAF gene, which is crucial for evaluating cancer risk and recurrence.
Career Highlights
Throughout his career, Collin has worked with prominent companies in the biotechnology sector, including Gene Logic, Inc. and Genomic Health, Inc. His work in these organizations has contributed to advancements in genomic health and cancer diagnostics.
Collaborations
Collin has collaborated with esteemed colleagues such as Kevin McLoughlin and Victor M Markowitz, further enhancing the impact of his research and innovations in the field.
Conclusion
Francois Collin's contributions to cancer research through his innovative patents and collaborations highlight his role as a significant inventor in the biotechnology industry. His work continues to influence the assessment and understanding of cancer, paving the way for future advancements in medical science.